Published in Pediatrics on January 01, 2000
Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn. JAMA (2015) 3.20
Superoxide dismutase improves oxygenation and reduces oxidation in neonatal pulmonary hypertension. Am J Respir Crit Care Med (2006) 1.54
Impact of early surfactant and inhaled nitric oxide therapies on outcomes in term/late preterm neonates with moderate hypoxic respiratory failure. J Perinatol (2013) 1.49
Neonatal pulmonary hypertension. Pediatr Crit Care Med (2010) 1.40
Superoxide dismutase restores eNOS expression and function in resistance pulmonary arteries from neonatal lambs with persistent pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol (2008) 1.38
Advances in the diagnosis and management of persistent pulmonary hypertension of the newborn. Pediatr Clin North Am (2009) 1.31
Prenatal exposure to antidepressants and persistent pulmonary hypertension of the newborn: systematic review and meta-analysis. BMJ (2014) 1.28
New insights into perinatal depression: pathogenesis and treatment during pregnancy and postpartum. Dialogues Clin Neurosci (2011) 1.17
Oxygen concentration and pulmonary hemodynamics in newborn lambs with pulmonary hypertension. Pediatr Res (2009) 1.14
Inhibition of the SDF-1/CXCR4 axis attenuates neonatal hypoxia-induced pulmonary hypertension. Circ Res (2009) 1.14
SOD and inhaled nitric oxide normalize phosphodiesterase 5 expression and activity in neonatal lambs with persistent pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol (2010) 1.11
Mitochondrial oxidant stress increases PDE5 activity in persistent pulmonary hypertension of the newborn. Respir Physiol Neurobiol (2010) 1.11
Increased incidence of idiopathic persistent pulmonary hypertension in Down syndrome neonates. Pediatr Cardiol (2007) 1.09
Prevalence of congenital heart defects and persistent pulmonary hypertension of the neonate with Down syndrome. Eur J Pediatr (2010) 1.07
Update on PPHN: mechanisms and treatment. Semin Perinatol (2014) 1.06
Antidepressant use during pregnancy: current controversies and treatment strategies. Clin Obstet Gynecol (2009) 1.03
Neonatal intensive care unit census influences discharge of moderately preterm infants. Pediatrics (2007) 1.03
Cross talk between NADPH oxidase and autophagy in pulmonary artery endothelial cells with intrauterine persistent pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol (2012) 0.99
Milrinone enhances relaxation to prostacyclin and iloprost in pulmonary arteries isolated from lambs with persistent pulmonary hypertension of the newborn. Pediatr Crit Care Med (2009) 0.97
Pulmonary vasodilator therapy in the NICU: inhaled nitric oxide, sildenafil, and other pulmonary vasodilating agents. Clin Perinatol (2012) 0.94
Advances in the management of meconium aspiration syndrome. Int J Pediatr (2011) 0.92
Persistent pulmonary hypertension of the newborn. Matern Health Neonatol Perinatol (2015) 0.90
Diagnosis and treatment of pulmonary hypertension in infancy. Early Hum Dev (2013) 0.88
Phosphodiesterases: emerging therapeutic targets for neonatal pulmonary hypertension. Handb Exp Pharmacol (2011) 0.87
Variations in CRHR1 are associated with persistent pulmonary hypertension of the newborn. Pediatr Res (2011) 0.87
Adenosine monophosphate-activated protein kinase is required for pulmonary artery smooth muscle cell survival and the development of hypoxic pulmonary hypertension. Am J Respir Cell Mol Biol (2013) 0.87
High prevalence of minor neurologic deficits in a long-term neurodevelopmental follow-up of children with severe persistent pulmonary hypertension of the newborn: a cohort study. Ital J Pediatr (2010) 0.87
Severe persistent pulmonary hypertension of the newborn in a setting where limited resources exclude the use of inhaled nitric oxide: successful treatment with sildenafil. Eur J Pediatr (2005) 0.86
Persistent pulmonary hypertension of the newborn. J Formos Med Assoc (2013) 0.86
AMP kinase activation improves angiogenesis in pulmonary artery endothelial cells with in utero pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol (2012) 0.85
Antidepressant use in pregnant and postpartum women. Annu Rev Clin Psychol (2013) 0.85
Antenatal hypoxia and pulmonary vascular function and remodeling. Curr Vasc Pharmacol (2013) 0.84
Effect of chronic perinatal hypoxia on the role of rho-kinase in pulmonary artery contraction in newborn lambs. Am J Physiol Regul Integr Comp Physiol (2012) 0.84
Toxicity of prolonged high dose inhaled PGE1 in ventilated neonatal pigs. Pulm Pharmacol Ther (2008) 0.82
The pulmonary circulation in neonatal respiratory failure. Clin Perinatol (2012) 0.82
Nitric oxide administration using an oxygen hood: a pilot trial. PLoS One (2009) 0.82
Risk factors associated with intracranial hemorrhage in neonates with persistent pulmonary hypertension on ECMO. J Intensive Care (2015) 0.82
Isolation of pulmonary artery smooth muscle cells from neonatal mice. J Vis Exp (2013) 0.82
Persistent Pulmonary Hypertension of the Newborn. Neoreviews (2015) 0.81
Trends in pediatric pulmonary hypertension-related hospitalizations in the United States from 2000-2009. Pulm Circ (2015) 0.81
Inhaled epoprostenol therapy for pulmonary hypertension: Improves oxygenation index more consistently in neonates than in older children. Pulm Circ (2012) 0.81
Regulation of phosphodiesterase 3 in the pulmonary arteries during the perinatal period in sheep. Pediatr Res (2009) 0.81
Nonsteroidal antiinflammatory drugs in late pregnancy and persistent pulmonary hypertension of the newborn. Pediatrics (2012) 0.81
Correlation of echocardiographic markers and therapy in persistent pulmonary hypertension of the newborn. Pediatr Cardiol (2008) 0.80
Jet nebulization of prostaglandin E1 during neonatal mechanical ventilation: stability, emitted dose and aerosol particle size. Pharmacol Res (2007) 0.80
Use of "kangaroo care" to alleviate the intensity of vaccination pain in newborns. Iran J Pediatr (2011) 0.80
Right ventricular echocardiographic indices predict poor outcomes in infants with persistent pulmonary hypertension of the newborn. Eur Heart J Cardiovasc Imaging (2015) 0.79
Considerations in the management of hypoxemic respiratory failure and persistent pulmonary hypertension in term and late preterm neonates. J Perinatol (2016) 0.79
Hydrocortisone normalizes phosphodiesterase-5 activity in pulmonary artery smooth muscle cells from lambs with persistent pulmonary hypertension of the newborn. Pulm Circ (2014) 0.79
Pharmacologic strategies in neonatal pulmonary hypertension other than nitric oxide. Semin Perinatol (2016) 0.79
Therapeutic approaches using nitric oxide in infants and children. Free Radic Biol Med (2011) 0.79
Pharmacotherapy for pulmonary hypertension. Pediatr Clin North Am (2012) 0.78
Respiratory support in meconium aspiration syndrome: a practical guide. Int J Pediatr (2012) 0.78
EDN1 Gene Variant is Associated with Neonatal Persistent Pulmonary Hypertension. Sci Rep (2016) 0.77
Antenatal betamethasone improves postnatal transition in late preterm lambs with persistent pulmonary hypertension of the newborn. Pediatr Res (2013) 0.76
Risk factors and outcomes of persistent pulmonary hypertension of the newborn in neonatal intensive care unit of Al-minya university hospital in egypt. J Clin Neonatol (2013) 0.76
Treatment of nonpsychotic major depression during pregnancy: patient safety and challenges. Drug Healthc Patient Saf (2014) 0.76
An opportunistic study evaluating pharmacokinetics of sildenafil for the treatment of pulmonary hypertension in infants. J Perinatol (2016) 0.75
The fetal circulation, pathophysiology of hypoxemic respiratory failure and pulmonary hypertension in neonates, and the role of oxygen therapy. J Perinatol (2016) 0.75
Perinatal nitric oxide therapy prevents adverse effects of perinatal hypoxia on the adult pulmonary circulation. Biomed Res Int (2014) 0.75
Evaluation of a pumpless lung assist device in hypoxia-induced pulmonary hypertension in juvenile piglets. Pediatr Res (2009) 0.75
Salidroside exerts protective effects against chronic hypoxia-induced pulmonary arterial hypertension via AMPKα1-dependent pathways. Am J Transl Res (2016) 0.75
Nogo-B Receptor Modulates Pulmonary Artery Smooth Muscle Cell Function in Developing Lungs. Am J Respir Cell Mol Biol (2016) 0.75
The Role of Serotonin Transporter in Human Lung Development and in Neonatal Lung Disorders. Can Respir J (2017) 0.75
Pulmonary hypertension-hyperventilation versus alkali infusion. Pediatrics (2001) 0.75
Fetal lung apparent diffusion coefficient measurement using diffusion-weighted MRI at 3 Tesla: Correlation with gestational age. J Magn Reson Imaging (2016) 0.75
Inhaled pulmonary vasodilators for persistent pulmonary hypertension of the newborn: safety issues relating to drug administration and delivery devices. Med Devices (Auckl) (2016) 0.75
Management of Supplemental Oxygen for Infants with Persistent Pulmonary Hypertension of Newborn: A Survey. Am J Perinatol (2016) 0.75
A Descriptive Study on the Neonatal Morbidity Profile of Autism Spectrum Disorders, Including a Comparison with Other Neurodevelopmental Disorders. J Autism Dev Disord (2015) 0.75
Context in Quality of Care: Improving Teamwork and Resilience. Clin Perinatol (2017) 0.75
Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr (1978) 15.97
Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group. J Clin Oncol (1999) 9.22
Epidemiologic assessment of the role of blood pressure in stroke. The Framingham study. JAMA (1970) 6.42
Very low birth weight outcomes of the National Institute of Child health and human development neonatal research network, January 1995 through December 1996. NICHD Neonatal Research Network. Pediatrics (2001) 5.58
Congenital heart disease in 56,109 births. Incidence and natural history. Circulation (1971) 5.55
Photonic detection of bacterial pathogens in living hosts. Mol Microbiol (1995) 5.24
Endemic cholera in rural Bangladesh, 1966-1980. Am J Epidemiol (1982) 4.93
Bioluminescent indicators in living mammals. Nat Med (1998) 4.71
Neurodevelopmental and functional outcomes of extremely low birth weight infants in the National Institute of Child Health and Human Development Neonatal Research Network, 1993-1994. Pediatrics (2000) 4.49
Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Network. Pediatrics (1991) 4.02
Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med (2001) 3.77
Surveillance of patients attending a diarrhoeal disease hospital in Bangladesh. Br Med J (Clin Res Ed) (1982) 3.75
Low-dose indomethacin and prevention of intraventricular hemorrhage: a multicenter randomized trial. Pediatrics (1994) 3.74
Visualizing gene expression in living mammals using a bioluminescent reporter. Photochem Photobiol (1997) 3.47
Tuberculosis in unvaccinated children, adolescents, and young adults: a city epidemic. Br Med J (Clin Res Ed) (1983) 3.34
Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia. Circulation (1974) 3.29
Vitamin A supplementation for extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med (1999) 3.11
Description and evaluation of a program for the early discharge of infants from a neonatal intensive care unit. J Pediatr (1995) 2.97
A regularity statistic for medical data analysis. J Clin Monit (1991) 2.74
Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1993 through December 1994. Am J Obstet Gynecol (1998) 2.72
Late-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr (1996) 2.70
Results at age 8 years of early intervention for low-birth-weight premature infants. The Infant Health and Development Program. JAMA (1997) 2.66
Clinical parameters do not adequately predict outcome in necrotizing enterocolitis: a multi-institutional study. J Perinatol (2008) 2.64
Infection of the newborn with herpesvirus hominis. Adv Pediatr (1970) 2.61
Assessment of the risk of the respiratory-distress syndrome by a rapid test for surfactant in amniotic fluid. N Engl J Med (1972) 2.56
Prenatal and intrapartum high-risk screening. I. Prediction of the high-rish neonate. Am J Obstet Gynecol (1973) 2.56
The Maternal Lifestyle Study: drug use by meconium toxicology and maternal self-report. Pediatrics (2001) 2.55
Practice parameter: neuroimaging of the neonate: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology (2002) 2.51
Predisposition for cholera of individuals with O blood group. Possible evolutionary significance. Am J Epidemiol (1985) 2.49
Conventional consent with opting in versus simplified consent with opting out: an exploratory trial for studies that do not increase patient risk. J Pediatr (1998) 2.46
Outcomes of children of extremely low birthweight and gestational age in the 1990's. Early Hum Dev (1999) 2.40
Varicella vaccine in pregnancy. BMJ (1996) 2.38
Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants. Pediatrics (1995) 2.38
A half century of neonatal sepsis at Yale: 1928 to 1978. Am J Dis Child (1981) 2.36
Isolation and characterization of the beta-ketoacyl-acyl carrier protein synthase III gene (fabH) from Escherichia coli K-12. J Biol Chem (1992) 2.35
Effects of early erythropoietin therapy on the transfusion requirements of preterm infants below 1250 grams birth weight: a multicenter, randomized, controlled trial. Pediatrics (2001) 2.34
Follow-up of low birth weight infants--the predictive value of maternal visiting patterns. Pediatrics (1972) 2.29
Longitudinal growth of hospitalized very low birth weight infants. Pediatrics (1999) 2.29